Dennis W. Nielson

Pediatrics

400 Parnassus Ave Fl 2
San Francisco, CA 94143

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Early acquisition and conversion of Pseudomonas aeruginosa in Hispanic youth with cystic fibrosis in the United States.

Early acquisition and conversion of Pseudomonas aeruginosa in Hispanic youth with cystic fibrosis in the United States.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: May 22, 2020

CFTR modulator therapy for cystic fibrosis caused by the rare c.3700A>G mutation.

CFTR modulator therapy for cystic fibrosis caused by the rare c.3700A>G mutation.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: April 29, 2020

Nanomolar-potency 'co-potentiator' therapy for cystic fibrosis caused by a defined subset of minimal function CFTR mutants.

Nanomolar-potency 'co-potentiator' therapy for cystic fibrosis caused by a defined subset of minimal function CFTR mutants.

Journal: Scientific reports

Published: August 27, 2019

Regional variations in longitudinal pulmonary function: A comparison of Hispanic and non-Hispanic subjects with cystic fibrosis in the United States.

Regional variations in longitudinal pulmonary function: A comparison of Hispanic and non-Hispanic subjects with cystic fibrosis in the United States.

Journal: Pediatric pulmonology

Published: March 05, 2019

Combination potentiator ('co-potentiator') therapy for CF caused by CFTR mutants, including N1303K, that are poorly responsive to single potentiators.

Combination potentiator ('co-potentiator') therapy for CF caused by CFTR mutants, including N1303K, that are poorly responsive to single potentiators.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: March 06, 2018

Pulmonary function disparities exist and persist in Hispanic patients with cystic fibrosis: A longitudinal analysis.

Pulmonary function disparities exist and persist in Hispanic patients with cystic fibrosis: A longitudinal analysis.

Journal: Pediatric pulmonology

Published: May 31, 2017

Correctors and Potentiators Rescue Function of the Truncated W1282X-Cystic Fibrosis Transmembrane Regulator (CFTR) Translation Product.

Correctors and Potentiators Rescue Function of the Truncated W1282X-Cystic Fibrosis Transmembrane Regulator (CFTR) Translation Product.

Journal: The Journal of biological chemistry

Published: October 25, 2016

In vivo and in vitro ivacaftor response in cystic fibrosis patients with residual CFTR function: N-of-1 studies.

In vivo and in vitro ivacaftor response in cystic fibrosis patients with residual CFTR function: N-of-1 studies.

Journal: Pediatric pulmonology

Published: August 02, 2016

Improving transition from paediatric to adult cystic fibrosis care: programme implementation and evaluation.

Improving transition from paediatric to adult cystic fibrosis care: programme implementation and evaluation.

Journal: BMJ quality & safety

Published: January 14, 2014

Normalization of sweat chloride concentration and clinical improvement with ivacaftor in a patient with cystic fibrosis with mutation S549N.

Normalization of sweat chloride concentration and clinical improvement with ivacaftor in a patient with cystic fibrosis with mutation S549N.

Journal: Chest

Published: October 02, 2013

Novel CFTR variants identified during the first 3 years of cystic fibrosis newborn screening in California.

Novel CFTR variants identified during the first 3 years of cystic fibrosis newborn screening in California.

Journal: The Journal of molecular diagnostics : JMD

Published: November 13, 2012

Management of plastic bronchitis with topical tissue-type plasminogen activator.

Management of plastic bronchitis with topical tissue-type plasminogen activator.

Journal: Pediatrics

Published: July 18, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026